欢迎来到天天文库
浏览记录
ID:45498321
大小:15.79 KB
页数:7页
时间:2019-11-13
《血液透析联合血液灌流治疗尿毒症脑病85例临床分析》由会员上传分享,免费在线阅读,更多相关内容在教育资源-天天文库。
1、血液透析联合血液灌流治疗尿毒症脑病85例临床分析[摘要]目的探析尿毒癥脑病患者应用血液透析联合血液灌流治疗的效果。方法2012年10月—2017年10月在该院接受治疗的尿毒症脑病患者中随机选择85例并分为参考组(n=41)和探析组(n=44),所有患者均接受饮食控制治疗、促红细胞生成素以及降压等常规治疗,同时接受血液透析治疗,探析组患者联合应用血液透析、血液灌流治疗。结果探析组总有效率为97.73%,参考组为82.93%,2组疗效差异有统计学意义(χ2=9.4712,P=0.0215)。治疗后探析组患者钾离子明显低于参考组,2组
2、差异有统计学意义(t=8.2237,P=0.0189),钠离子明显较参考组患者低,2组差异有统计学意义(t=21.7372,P=0.0026),探析组患者肌酐低于参考组,2组差异有统计学意义(t=24.7247,P=0.0378),尿素氮低于参考组,2组差异有统计学意义(t=5.2739,P=0.0173),β2-微球蛋白低于参考组,2组差异有统计学意义(t=9.7256,P=0.0371)。结论尿毒症脑病患者应用血液透析联合血液灌流治疗有助于保持电解质平衡,对于保护患者肾功能以及促进其临床症状改善均可发挥积极作用。[关键词]血
3、液透析;血液灌流;尿毒症脑病[中图分类号]R692.5[文献标识码]A[文章编号]1674-0742(2018)10(b)-0046-03[Abstract]ObjectiveToanalyzetheeffectofhemodialysiscombinedwithbloodperfusiontherapyinpatientswithuremiaencephalopathy.MethodsFromOctober2012toOctober2017,85patientswithuremicencephalopathywhoweretr
4、eatedinthehospitalwererandomlyselectedanddividedintoreferencegroup(n=41)andprobinggroup(n=44).Allpatientsreceiveddietcontroltreatment,erythropoietinandantihypertensivetreatment,andhemodialysistreatment,combinedwithhemodialysis,bloodperfusiontherapy.ResultsThetotaleff
5、ectiveratewas97.73%intheprobinggroupand82.93%inthereferencegroup.Thedifferenceintheefficacybetweenthetwogroupswasstatisticallysignificant(χ2=9.4712,P=0.0215).Aftertreatment,thepotassiumionintheprobinggroupwassignificantlylowerthanthatinthereferencegroup.Thedifference
6、betweenthetwogroupswasstatisticallysignificant(t=8.2237,P=0.0189).Thesodiumionwassignificantlylowerthanthatofthereferencegroup.Thedifferencebetweenthetwogroupswasstatisticallysignificant(t=21.7372,P=0.0026),thecreatinineofthepatientsintheanalysisgroupwaslowerthanther
7、eferencegroup,thedifferencebetweenthetwogroupswasstatisticallysignificant(t=24.7247,P=0.0378),theureanitrogenwaslowerthanthereferencegroup,andthedifferencebetweenthetwogroupswasstatisticallysignificant(t=5.2739,P=0.0173),β2-microglobulinwaslowerthanthereferencegroup,
8、andthedifferencebetweenthetwogroupswasstatisticallysignificant(t=9.7256,P=0.0371).ConclusionHemodialysiscombinedwithhemoperfusionin
此文档下载收益归作者所有